Health policy

1.Identify examples of how the market for health care is different than the market for other services. 2.Using the economic principle that overall cost = unit price x quantity, discuss which types of prevention may increase overall costs and which may save the health care system money. The supporting rational references are to be in APA format both in the body and noting the completed references at the end of the post. You need at least one reference from the literature and a reference from the module to support your post to count as acceptable. As graduate students you are lending depth and breath through noting the evidence in published work. Please do not reference a web site; you need to get into the published body of knowledge to support your work. Recommended readings from Module The module is the power point attached in this order(it has a video; mediasite.umaryland.edu reference: Mech, A., JD, RN, Assistant Professor, OSAH Coordinator, Legal Affairs, SPI. (2014.). Economic principles in the healthcare market. Lecture. Retrieved September 12, 2016. For the literature I have the links below: Challenges of Generating Revenue in Rural Areas : aarp.org doctors-hospitals 2.html Examples of Monopolies in Health Care: healthaffairs.org 2011/09/06/monopoly-anyone- the-battle-to-control-health- care/ Health System CEO fears Monopoly (Pittsburgh): triblive.com Hospital Monopolies (Boston): forbes.com aroy monopolies-the-biggest-driver- of-health-costs-that-nobody- talks-about/ From the Washington Post, an example of provider behavior to maximize reimbursement from a health insurer, in this case Medicare www.washingtonpost.com Read about the cost to the health care system of false-positive mammograms and breast cancer overdiagnosis content.healthaffairs.org Review the CMS data on healthcare spending in the US www.cms.gov What has been driving recent increases in total spending? You will then respond to the questions below after writing the paper. This response doesn’t require references. (let’s chart to clarify, if you have question for me): 1) The assigned article, “New Hepatitis C Drugs’ price prompts an ethical debate: Who deserves to get them?”, provides the reader with lay perspective concerning the price of new hepatic drugs: Sovaldi and Olysio. According to the Washington Post article, a 12-week treatment plan with Sovaldi can cost a patient around $84,000. Despite the price, the article states that providers feel as though these drugs should be used with major hepatic impairment as opposed to early, asymptomatic hepatitis. Be that as it may, high prices for pharmaceuticals do not only exist for Hepatitis C infections. In my practice field of psychiatry, a new antidepressant, Tritellix (vortioxetine), can cost a patient $400 for a 30-day supply. Even though it is not as pricey as the $24,000 price of Sovaldi, it still remains out-of-reach for many psychiatric patients for whom traditional antidepressants have not worked. With regard to your given practice field or specialty, have you come across similar medication hurdles with regard to pricing? What experiences have you had where a patient could not pay for the prescribed treatment modality? 2) As a continuation of question number one, nurses practice on the basis of nursing ethics. Our actions are to promote beneficence and nonmaleficence. With regard to ethical nursing principles – is it ethical to prescribe a treatment modality that a patient may not have the wherewithal to obtain? Additionally, how do the principles of beneficence and nonmaleficence factor into provider reimbursement? 3) Professor Mech discusses variables related-to this country’s open-market system. With regard to her online lecture, what is allocation and how does the government use this principle in our healthcare system? 4) As future APRNs, reimbursement and “getting paid” are important factors in our care. With regard to reimbursement, what are differences between fee-for-service and prospective payment and how do reimbursement amounts differ between both methods?